Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
HR+
.
Show all posts
Showing posts with label
HR+
.
Show all posts
Friday, May 13, 2016
Pfizer Receives Expanded FDA Approval For Ibrance (palbociclib) In HR , HER2- Metastatic Breast Cancer
›
In continuation of my updates on palbociclib Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) h...
Wednesday, May 11, 2016
Pfizer Receives Expanded FDA Approval For Ibrance (palbociclib) In HR , HER2- Metastatic Breast Cancer
›
In continuation of my updates on palbociclib Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) h...
›
Home
View web version
